Sector: Pharmaceuticals & Biotechnology

Large Cap

Anthem Biosciences Share Price

ANTHEM

₹883.60

12.15(1.39%)

24th Aug 2026 | 3:28 PM

NSE : ANTHEM

Open Free Demat Account

Anthem Biosciences Performance

Price Movement

₹883.60

₹873.20

₹900.60

↘ Today's Low↗ Today's High

1 Year Performance

₹883.60

₹579.15

₹904.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹900.60

Low₹873.20

Open at₹873.20

Prev Close₹871.45

Volumes7.30 L

Avg Price₹888.62

Lower Circuit₹697.20

Upper Circuit₹1,045.70

Historical Performance

3M High₹904.00

3M Low₹732.00

1 Yr High₹904.00

1 Yr Low₹579.15

3 Yr High₹904.00

3 Yr Low₹579.15

5 Yr High₹904.00

5 Yr Low₹579.15

Summary

As of 25-08-2026 01:24, Anthem Biosciences Ltd. share price today is ₹0, with a change of ₹-871.45 (-100.00%) from the previous close of ₹871.45. The stock opened at ₹873.2 and traded between ₹873.2 and ₹900.6, with a total traded volume of 730332 shares. The company has a market capitalization of ₹49079.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹904 and ₹579.15, respectively.

Anthem Biosciences Ltd. valuation metrics include a P/E ratio of 85.2, EPS of ₹10.55, and book value of ₹15.50. Profitability indicators show ROE of 19.45% along with a dividend yield of 0.2%. Anthem Biosciences Ltd. has reported revenue of ₹2002.34 Cr and net profit of ₹575.94 Cr.

Anthem Biosciences Ltd. technical indicators include Day RSI at 62.38, Day MFI at 70.77, Day ADX at 36.72. Additional indicators include Commodity Channel Index (CCI) at 61.6 and Williams %R at -34.63. Momentum indicators show Day MACD at 27.01, Day MACD Signal Line at 26.31, DayATR at 23.32. Rate of Change indicators for Anthem Biosciences Ltd. include ROC125 at 25.71 and ROC21 at 12.03.

Exponential moving averages include EMA5 at ₹877.7, EMA10 at ₹871.4, EMA12 at ₹867.2, EMA20 at ₹850.5, EMA26 at ₹840.2, EMA50 at ₹812.7, EMA100 at ₹780.4, EMA200 at ₹755.5. Simple moving averages include SMA5 at ₹883.4, SMA10 at ₹880.5, SMA20 at ₹845.2, SMA30 at ₹820, SMA50 at ₹800.2, SMA100 at ₹775.2, SMA150 at ₹732.9, SMA200 at ₹715.3.

Support levels for Anthem Biosciences are placed at First Support ₹861.93, Second Support ₹852.42, Third Support ₹835.93. Resistance levels are seen at First Resistance ₹887.93, Second Resistance ₹904.42, Third Resistance ₹913.93. Anthem Biosciences Ltd. shareholding pattern shows promoter holding at 71.42%, FII holding at 2.57%, DII holding at 0%, public holding at 12.52%.

Anthem Biosciences Fundamentals

Market Cap

High in industry

49,079.60 Cr.

PE Ratio (TTM)

High in industry

85.20

Dividend Yield

Below industry Median

0.20

Net Profit TTM

14.1% incr over last year

575.94

Net Profit Growth

14.1% incr over last year

575.94

PEG Ratio

High in industry

ROE

3.9% incr over last year

19.45

Operating Revenue TTM

2,002.34

Operating Revenue Growth

2% decr over last year

Book Value

High in industry

15.50

MFI

MFI Overbought

70.77

RSI

RSI is mid-range

62.38

EPS (TTM)

10.55

Debt to Equity

0.02

Face Value

Operating Profit Margin Qtr.

36.57

Operating Profit Qtr.

150.57

Net Profit Qtr.

119.94

Operating Revenue Qtr.

418.22

PB Ratio

15.50

Anthem Biosciences Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	383.84	582.50	416.58	552.23	538.01
Operating Expense	253.01	315.51	253.53	326.57	342.58
Operating Profit	130.83	266.99	163.05	225.66	195.43
Depreciation	22.31	26.28	26.75	23.92	22.61
Interest	0.76	1.58	1.13	2.23	1.61
Tax	34.35	89.06	37.98	54.87	50.60
Net Profit	102.01	211.66	112.12	198.43	148.34

Anthem Biosciences Technicals

Anthem Biosciences Ltd. EMA & SMA

₹883.60

9.10 (1.04%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹877.7

Day EMA10 ₹871.4

Day EMA12 ₹867.2

Day EMA20 ₹850.5

Day EMA26 ₹840.2

Day EMA50 ₹812.7

Day EMA100 ₹780.4

Day EMA200 ₹755.5

Anthem Biosciences Support and Resistance

Resistance

First Resistance₹887.93

Second Resistance₹904.42

Third Resistance₹913.93

Support

First Support₹861.93

Second Support₹852.42

Third Support₹835.93

Technical Indicators

Day RSI62.38

Day MFI70.77

Day ADX36.72

Day Commodity Channel Index61.60

William-34.63

Day MACD27.01

Day MACD Signal Line26.31

Day ATR23.32

Day ROC12525.71

Day ROC2112.03

Anthem Biosciences Shareholding Pattern

Held By	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	74.7	74.7	74.7	71.4
FII	1.7	1.4	1.3	2.6
DII	7.2	7.6	11.5	13.4
Public	16.4	16.3	12.5	12.5

Anthem Biosciences Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	4.52 L	8.34 L	54.20%
Week	4.65 L	7.05 L	65.95%
1 Month	4.11 L	7.04 L	58.38%
6 Month	5.61 L	8.17 L	68.70%

Anthem Biosciences SWOT Analysis

Strengths22

Weakness11

Opportunity4

Threats1

Benjamin Graham Value Screen

Expensive Stars (DVM)

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Annual Profit Growth higher than Sector Profit Growth

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

RSI indicating price strength

Volume Shockers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Anthem Biosciences Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
25 Jun, 2026	2	FINAL	26 Jun, 2026	Equity Share

Anthem Biosciences Stock Comparison

Financials	Rubicon Research Ltd.	Sai Life Science Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.
Price (₹)	₹1,766	₹1,436.80	₹1,862	₹2,374.50	₹212.43
% Change	2.39%	-1.41%	-0.05%	-0.40%	-0.58%
Revenue TTM (₹ Cr)	₹1,935.80	₹2,250.36	₹9,683.45	₹14,737.88	₹9,205.28
Net Profit TTM (₹ Cr)	₹288.22	₹361.74	₹1,011.39	₹2,042.67	₹-313.62
PE TTM	99.10	85.50	34.90	48.20	-90.70
1 Year Return	255.61	57.4	24.77	-8.55	10.85
ROCE	24.32	18.38	25.65	14.32	2.29

Similar Stocks

ACUTAAS

Acutaas Chemicals Ltd.

₹ 3171.00

+0.06%

GLAND

Gland Pharma Ltd.

₹ 2811.90

-0.26%

LAURUSLABS

Laurus Labs Ltd.

₹ 1801.00

-0.06%

ALKEM

Alkem Laboratories Ltd.

₹ 5350.00

-0.93%

BIOCON

Biocon Ltd.

₹ 409.40

-1.48%

DIVISLAB

Divi's Laboratories Ltd.

₹ 8496.00

-1.17%

GRANULES

Granules India Ltd.

₹ 857.00

-0.13%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3581.00

-1.62%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1103.80

-1.45%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2390.70

+3.14%

WOCKPHARMA

Wockhardt Ltd.

₹ 1902.00

+0.83%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1608.00

-0.82%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1910.00

+0.40%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 22901.00

-1.72%

IPCALAB

Ipca Laboratories Ltd.

₹ 1921.00

+0.51%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2930.00

+0.96%

PFIZER

Pfizer Ltd.

₹ 4886.00

-1.85%

ABBOTINDIA

Abbott India Ltd.

₹ 26450.00

+0.84%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4886.50

-0.20%

LUPIN

Lupin Ltd.

₹ 2188.00

-0.63%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1190.00

+1.30%

CIPLA

Cipla Ltd.

₹ 1437.90

+0.40%

FAQ's on ANTHEM

What are the PE and PB ratios for Anthem Biosciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Anthem Biosciences Ltd. is 85.2, and the Price-to-Book (PB) ratio is 15.5.

What is the 52-Week High and Low for Anthem Biosciences Ltd.?

Over the past 52 weeks, the highest price reached by Anthem Biosciences Ltd. shares was ₹ 904, and the lowest price was ₹ 579.15.

Who are the major shareholders of Anthem Biosciences Ltd.?

Significant shareholdings in Anthem Biosciences Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Anthem Biosciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Anthem Biosciences Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Anthem Biosciences Ltd.?

Anthem Biosciences Ltd. last declared a FINAL dividend of ₹ 2 per share for the financial period ending 2026. The record date was set as 2026-06-25, and the payment was/is scheduled around 2026-06-25. For the most current dividend announcements, refer to official company filings.